CHEMBOND
Chembond Material Technologies Limited
Specialty chemicals for water treatment, construction and performance additives
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
chembondindia.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Stock price
₹190.37
Market cap
256 Cr
Stock P/E
17.5
P/B
1.53
Dividend yield
0.9%
ROE (FY26)
7.7%
ROCE (FY26)
9.3%
Operating margin (FY26)
5.8%
Debt / equity (FY26)
0.02
OCF / EBITDA (FY26)
81.8%
OCF / EBITDA (3Y)
76.5%
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Chembond Material Technologies (formerly Chembond Chemicals) makes specialty chemicals and animal-health products, including vitamins and minerals, probiotic and prebiotic enzymes, and feed additives and nutrition products.
Company snapshot
57thBy market cap
Ranked among 68 companies in Specialty Chemicals.
What we see
Positives
- ✓Debt-to-equity of 0.02x — the company is largely funded by its own money, not borrowed funds.
1 more signal from the filings.Sign in free to see them all
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 112 Cr | 115 Cr | 122 Cr | 109 Cr | 124 Cr | 126 Cr | 52 Cr | 58 Cr | 58 Cr | 63 Cr | 72 Cr | 72 Cr |
| Operating expenses (approx.) | 97 Cr | 100 Cr | 110 Cr | 100 Cr | 111 Cr | 108 Cr | 49 Cr | 54 Cr | 54 Cr | 59 Cr | 65 Cr | 69 Cr |
| EBITDA | 15 Cr | 14 Cr | 12 Cr | 9 Cr | 13 Cr | 18 Cr | 4 Cr | 3 Cr | 4 Cr | 4 Cr | 6 Cr | 3 Cr |
| OPM % | 13.0% | 12.4% | 9.6% | 8.3% | 10.3% | 14.2% | 6.9% | 6.0% | 7.0% | 6.6% | 9.0% | 4.1% |
| Other income | 9 Cr | 4 Cr | 1 Cr | 4 Cr | 5 Cr | 0.33 Cr | 2 Cr | 3 Cr | 0.13 Cr | 2 Cr | -2 Cr | 4 Cr |
| Interest | 0.46 Cr | 0.32 Cr | 0.13 Cr | 0.33 Cr | 0.31 Cr | 0.41 Cr | 0.14 Cr | 0.07 Cr | 0.10 Cr | 0.13 Cr | 0.07 Cr | 0.06 Cr |
| Depreciation | 1 Cr | 1 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 0.70 Cr | 0.68 Cr | 1 Cr | 0.81 Cr | 0.85 Cr | 0.85 Cr |
| Profit before tax | 22 Cr | 16 Cr | 11 Cr | 11 Cr | 17 Cr | 16 Cr | 4 Cr | 5 Cr | 3 Cr | 3 Cr | 4 Cr | 6 Cr |
| Tax % | 29.8% | 16.0% | 40.7% | 28.2% | 20.5% | 27.0% | 25.2% | 25.6% | -34.4% | 46.4% | 19.6% | 1.8% |
| Net profit | 15 Cr | 13 Cr | 7 Cr | 8 Cr | 14 Cr | 12 Cr | 3 Cr | 4 Cr | 4 Cr | 2 Cr | 3 Cr | 6 Cr |
| EPS (₹) | ₹11.48 | ₹10.04 | ₹4.99 | ₹5.93 | ₹10.31 | ₹8.71 | ₹2.50 | ₹2.97 | ₹2.85 | ₹1.18 | ₹2.59 | ₹4.26 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 321 Cr | 334 Cr | 301 Cr | 268 Cr | 274 Cr | 349 Cr | 440 Cr | 462 Cr | 201 Cr | 250 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 304 Cr | 312 Cr | 276 Cr | 258 Cr | 256 Cr | 332 Cr | 406 Cr | 413 Cr | 188 Cr | 232 Cr | Sign in free for the trailing twelve months |
| EBITDA | 17 Cr | 23 Cr | 25 Cr | 10 Cr | 18 Cr | 18 Cr | 35 Cr | 49 Cr | 14 Cr | 18 Cr | Sign in free for the trailing twelve months |
| OPM % | 5.3% | 6.7% | 8.5% | 3.7% | 6.6% | 5.0% | 7.9% | 10.7% | 6.7% | 7.2% | Sign in free for the trailing twelve months |
| Other income | 18 Cr | 11 Cr | 4 Cr | 3 Cr | 15 Cr | 8 Cr | 5 Cr | 17 Cr | 8 Cr | 3 Cr | Sign in free for the trailing twelve months |
| Interest | 1 Cr | 1 Cr | 0.78 Cr | 0.78 Cr | 0.42 Cr | 0.69 Cr | 1 Cr | 1 Cr | 0.64 Cr | 0.37 Cr | Sign in free for the trailing twelve months |
| Depreciation | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 5 Cr | 4 Cr | 5 Cr | 6 Cr | 3 Cr | 4 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 30 Cr | 28 Cr | 24 Cr | 8 Cr | 29 Cr | 21 Cr | 34 Cr | 60 Cr | 19 Cr | 16 Cr | Sign in free for the trailing twelve months |
| Tax % | 24.3% | 15.5% | 18.7% | 60.9% | 28.5% | 31.9% | 26.4% | 26.0% | 9.8% | 16.9% | Sign in free for the trailing twelve months |
| Net profit | 23 Cr | 24 Cr | 20 Cr | 3 Cr | 20 Cr | 14 Cr | 25 Cr | 44 Cr | 18 Cr | 13 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹14.40 | ₹16.34 | ₹12.88 | ₹1.39 | ₹15.13 | ₹10.35 | ₹18.36 | ₹33.02 | ₹13.06 | ₹9.59 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 0.0% | 21.6% | 27.2% | 9.1% | 26.8% | 18.3% | Sign in free for the trailing twelve months |
Sign in free for the trailing twelve months
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 7 Cr | 7 Cr | 7 Cr | 7 Cr | 7 Cr | 7 Cr | 7 Cr | 7 Cr | 7 Cr | 7 Cr |
| Reserves | 223 Cr | 242 Cr | 255 Cr | 262 Cr | 286 Cr | 297 Cr | 315 Cr | 355 Cr | 149 Cr | 160 Cr |
| Borrowings | 9 Cr | 9 Cr | 7 Cr | 3 Cr | 2 Cr | 2 Cr | 7 Cr | 7 Cr | 3 Cr | 4 Cr |
| Other liabilities | 64 Cr | 66 Cr | 50 Cr | 45 Cr | 58 Cr | 54 Cr | 71 Cr | 78 Cr | 43 Cr | 48 Cr |
| Total liabilities | 321 Cr | 325 Cr | 322 Cr | 322 Cr | 354 Cr | 361 Cr | 402 Cr | 447 Cr | 202 Cr | 219 Cr |
| Fixed assets (net) | 42 Cr | 46 Cr | 45 Cr | 48 Cr | 46 Cr | 45 Cr | 41 Cr | 47 Cr | 33 Cr | 40 Cr |
| CWIP | 2 Cr | 0.67 Cr | 2 Cr | 0.07 Cr | 0.37 Cr | 0.70 Cr | 12 Cr | 13 Cr | 8 Cr | 2 Cr |
| Investments | 150 Cr | 76 Cr | 58 Cr | 51 Cr | 73 Cr | 75 Cr | 65 Cr | 92 Cr | 78 Cr | 70 Cr |
| Loans & advances | — | — | 0.41 Cr | 0.46 Cr | 0.35 Cr | 0.23 Cr | 0.46 Cr | 0.11 Cr | 0.0025 Cr | 0 Cr |
| Inventories | 28 Cr | 25 Cr | 25 Cr | 27 Cr | 29 Cr | 34 Cr | 34 Cr | 33 Cr | 16 Cr | 20 Cr |
| Trade receivables | 67 Cr | 81 Cr | 91 Cr | 82 Cr | 84 Cr | 90 Cr | 115 Cr | 120 Cr | 40 Cr | 53 Cr |
| Cash & bank | 4 Cr | 10 Cr | 5 Cr | 2 Cr | 10 Cr | 9 Cr | 9 Cr | 10 Cr | 6 Cr | 9 Cr |
| Other assets | 28 Cr | 86 Cr | 95 Cr | 110 Cr | 112 Cr | 107 Cr | 124 Cr | 131 Cr | 21 Cr | 25 Cr |
| Total assets | 321 Cr | 325 Cr | 322 Cr | 322 Cr | 354 Cr | 361 Cr | 402 Cr | 447 Cr | 202 Cr | 219 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 5 Cr | -12 Cr | -12 Cr | 24 Cr | 25 Cr | -0.0082 Cr | 2 Cr | 28 Cr | 19 Cr | 15 Cr |
| Cash from investing | -0.28 Cr | 19 Cr | 14 Cr | -12 Cr | -11 Cr | -2 Cr | 0.14 Cr | -22 Cr | -8 Cr | -10 Cr |
| Cash from financing | -3 Cr | -4 Cr | -6 Cr | -11 Cr | -2 Cr | -4 Cr | -2 Cr | -5 Cr | -9 Cr | -1 Cr |
| Net cash flow | 2 Cr | 3 Cr | -5 Cr | 0.55 Cr | 12 Cr | -6 Cr | 0.25 Cr | 0.88 Cr | 2 Cr | 3 Cr |
| Free cash flow (OCF − Capex) | -0.99 Cr | -76 Cr | -21 Cr | 4 Cr | 21 Cr | -4 Cr | -12 Cr | 16 Cr | 15 Cr | -6 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 12.3% | 11.2% | 9.3% | 3.1% | 9.8% | 6.9% | 10.5% | 16.5% | 12.7% | 9.3% |
| ROE % | 7.8% | 8.8% | 6.5% | 0.7% | 6.9% | 4.6% | 7.6% | 12.2% | 11.2% | 7.7% |
| Debtor days | 76 | 88 | 110 | 112 | 111 | 93 | 95 | 95 | 72 | 77 |
| Inventory days | 59 | 47 | 61 | 81 | 88 | 75 | 65 | 59 | 51 | 49 |
| Days payable | 95 | 98 | 90 | 101 | 129 | 86 | 101 | 96 | 103 | 87 |
| Cash conversion cycle | 41 | 37 | 81 | 92 | 69 | 82 | 59 | 58 | 20 | 39 |
| OCF / EBITDA % | 28.9% | -54.5% | -47.9% | 237.0% | 137.6% | -0.0% | 6.3% | 56.1% | 143.4% | 81.8% |
| OCF / EBITDA % (3 years) | — | — | -30.2% | -1.4% | 68.0% | 106.5% | 38.7% | 29.4% | 50.6% | 76.5% |
| Debt / equity | 0.04 | 0.04 | 0.03 | 0.01 | 0.0064 | 0.0050 | 0.02 | 0.02 | 0.02 | 0.02 |
| Current ratio | 2.94 | 2.13 | 3.08 | 3.50 | 3.17 | 3.59 | 2.72 | 3.07 | 2.23 | 2.37 |
| Net debt / EBITDA | 0.31 | -0.04 | 0.05 | 0.09 | -0.43 | -0.43 | -0.06 | -0.07 | -0.25 | -0.29 |